Log in
Enquire now
Abolis

Abolis

Provider of tailor-made industrial solutions based on natural and genetically modified microorganisms.

OverviewStructured DataIssuesContributors

Contents

abolis.fr
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Consumer biotechnology
Consumer biotechnology
Technology
Technology
Synthetic biology
Synthetic biology
Biology
Biology
Biotechnology
Biotechnology
Location
France
France
Évry, Yonne
Évry, Yonne
B2X
B2B
B2B
CEO
‌
Cyrille Pauthenier
Founder
‌
Cyrille Pauthenier
‌
Valerie Brunel
Number of Employees (Ranges)
51 – 200
Investors
ICOS Capital Management
ICOS Capital Management
Evonik Venture Capital
Evonik Venture Capital
Bold
Bold
‌
DeepTech & Climate Fonds (DTCF)
‌
Clay Capital
Founded Date
January 1, 2014
Total Funding Amount (USD)
38,800,000
Latest Funding Round Date
September 12, 2024
Latest Funding Type
Series B
Series B
Country
France
France

Other attributes

Latest Funding Round Amount (USD)
38,800,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Abolis

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us